Transports Are Truckin' Ahead of Earnings

Last 12-Month Return (%): Stocks with a red number declined by that percentage over the last 12 months. Stocks with a black number increased by that percentage over the past 12 months.

Forecast One-Year Return: Stocks with a red number are projected to decline by that percentage over the next 12 months. Stocks with a black number in the table are projected to move higher by that percentage over the next 12 months.

Price-to-earnings ratios appear elevated.

Value Level: the price at which to enter a good-'til-canceled limit order to buy on weakness. The letters mean: W-Weekly, M-Monthly, Q-Quarterly, S-Semiannual and A-Annual.

Pivot: A level between a value level and risky level that should be a magnet during the time frame noted.

Risky Level: the price at which to enter a GTC limit order to sell on strength.

Among the eight stocks in today's profiles, four are undervalued and four are overvalued, seven have buy ratings and one has a hold rating. The performance measure shows that four have had double-digit gains over the last 12 months and shows a double-digit loss. All are projected to be higher 12 months from now. The 12-month trailing P/E ratios range from 11.9 to 23.5.

Con-Way (CNW) ($31.36) closed Tuesday just above its 200-day SMA at $31.13 with overbought momentum. The weekly chart is positive, with the five-week MMA at $29.22 and the 200-week SMA at $32.48. The stock has a hold rating and is 18.6% undervalued. My monthly value level is $29.19, with a weekly pivot at $30.80 and a quarterly risky level at $33.43.

CSX (CSX) ($20.78 vs. $19.95 on Dec. 24) has a positive daily chart with the stock below its 200-day SMA at $21.45. The weekly chart is positive, with the five-week MMA at $20.34 and the 200-week SMA at $19.41. The stock remains buy-rated, with my monthly value level at $19.73, weekly pivot at $21.11 and quarterly risky level at $22.31.

FedEx (FDX) ($98.67 vs. $92.74 on Dec. 24) set a multiyear high at $98.79 on Tuesday. FDX reported its quarterly results on Dec. 19 and missed EPS estimates by 2 cents. The daily chart is extremely overbought, and the weekly chart is positive, with the five-week MMA at $93.56 and the 200-week SMA at $83.13. The stock remains buy-rated, with my monthly value level at $91.37, weekly pivot at $98.21 and semiannual risky level at $103.76.

« First ‹ Previous 1 2 3 Next › Last »